HowToGeek on MSN
Plex forced me to start paying—but now I'm glad it did
One of the biggest features that (controversially) sits behind the Plex paywall is hardware transcoding. This is where a special video encoding chip built into your computer can handle the work of ...
How-To Geek on MSN
Plex server changes, the new Visual Studio Code, and more: News roundup
Visual Studio Code and other lightweight editors might be the most popular choices for Python programming, but JetBrains PyCharm is still great for complex projects and debugging. The latest update is ...
If you want to explore all the channels Google TV Freeplay offers, along with the 1,000+ other free live TV channels across ...
Overview: Repurpose old Android phones as media servers to stream music, videos, and take photos at home.Using apps like Plex, Kodi, or BubbleUPnP, you can acce ...
Lund, Sweden, 16 December 2025. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced that GOOD-IDES-02, a global pivotal Phase 3 trial in anti-glomerular basement membrane (anti-GBM) ...
This is Lowpass by Janko Roettgers, a newsletter on the ever-evolving intersection of tech and entertainment, syndicated just for The Verge subscribers once a week. Lowpass is taking a winter break ...
HowToGeek on MSN
5 great reasons to unplug your computer overnight
It may be tempting to leave your PC on overnight. After all, it can go into sleep mode, which should theoretically limit its ...
A pirate activist group has reportedly scraped and released metadata from Spotify, and intends to release 86 million audio files.
The Roku Channel just got even larger right before the holidays, wrapping up an impressive year for the FAST service.
At a glance Expert's Rating Pros ・High transfer speed ・Compact design ・Many upgrade options ・HDMI connection Cons ・High price ...
PETACH TIKVA, Israel, Dec. 16, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced ...
Lund, Sweden, 16 December 2025. Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), today announced that GOOD-IDES-02, a global pivotal Phase 3 trial in anti-glomerular basement membrane (anti-GBM) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results